MIM
Monashee Investment Management Portfolio holdings
AUM
$190M
This Quarter Return
+18.74%
1 Year Return
+42.84%
3 Year Return
+185.9%
5 Year Return
+237.5%
10 Year Return
+2,730.86%
AUM
$845M
AUM Growth
+$845M
(+49%)
Cap. Flow
+$228M
Cap. Flow
% of AUM
27.01%
Top 10 Holdings %
Top 10 Hldgs %
63.74%
Holding
124
New
76
Increased
6
Reduced
15
Closed
19
Top Buys
| 1 |
AB InBev
BUD
|
$16.4M |
| 2 |
SharkNinja
SN
|
$14.8M |
| 3 |
Kaspi.kz JSC
KSPI
|
$11.2M |
| 4 |
American Healthcare REIT
AHR
|
$9.88M |
| 5 |
ODDITY Tech
ODD
|
$8.91M |
Top Sells
| 1 |
PG&E
PCG
|
$4.69M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
$4.27M |
| 3 |
Structure Therapeutics
GPCR
|
$4.16M |
| 4 |
argenx
ARGX
|
$3.8M |
| 5 |
Las Vegas Sands
LVS
|
$3.69M |
Sector Composition
| 1 | Healthcare | 15.07% |
| 2 | Industrials | 5.62% |
| 3 | Technology | 5.05% |
| 4 | Consumer Discretionary | 2.94% |
| 5 | Consumer Staples | 2.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
REV Group
REVG
$2.6B
| $5.72M | 0.68% | +258,938 | New | +$5.72M |
|
27
CG Oncology
CGON
$2.04B
| $5.49M | 0.65% | +125,000 | New | +$5.49M |
|
28
Kinetik
KNTK
$2.57B
| $4.98M | 0.59% | 125,000 +60,100 | +93% | +$2.4M |
|
29
Korro Bio
KRRO
$217M
| $4.98M | 0.59% | 55,364 -35,441 | -39% | -$3.19M |
|
30
RadNet
RDNT
$5.52B
| $4.87M | 0.58% | +100,000 | New | +$4.87M |
|
31
Dyne Therapeutics
DYN
$1.92B
| $4.83M | 0.57% | +170,000 | New | +$4.83M |
|
32
Ichor Holdings
ICHR
$578M
| $4.75M | 0.56% | +122,960 | New | +$4.75M |
|
33
Symbotic
SYM
$5.28B
| $4.73M | 0.56% | +105,161 | New | +$4.73M |
|
34
Aquestive Therapeutics
AQST
$456M
| $4.26M | 0.5% | +1,000,000 | New | +$4.26M |
|
35
Gossamer Bio
GOSS
$562M
| $4.08M | 0.48% | 3,459,854 | – | – |
|
|
36
Structure Therapeutics
GPCR
$1.11B
| $4.06M | 0.48% | 94,714 -97,141 | -51% | -$4.16M |
|
37
NewAmsterdam Pharma
NAMS
$2.71B
| $4.02M | 0.48% | +170,000 | New | +$4.02M |
|
38
Matador Resources
MTDR
$6.27B
| $4.01M | 0.47% | +60,000 | New | +$4.01M |
|
39
Arcutis Biotherapeutics
ARQT
$1.86B
| $3.77M | 0.45% | +380,000 | New | +$3.77M |
|
40
Roivant Sciences
ROIV
$8.15B
| $3.69M | 0.44% | 350,000 | – | – |
|
41
TD Synnex
SNX
$12.2B
| $3.68M | 0.43% | +32,500 | New | +$3.68M |
|
42
Celldex Therapeutics
CLDX
$1.47B
| $3.67M | 0.43% | 87,500 -12,709 | -13% | -$533K |
|
43
Napco Security Technologies
NSSC
$1.36B
| $3.61M | 0.43% | +90,000 | New | +$3.61M |
|
44
Perella Weinberg Partners
PWP
$1.38B
| $3.56M | 0.42% | +252,066 | New | +$3.56M |
|
|
AUNA
45
Auna
AUNA
$466M
| $3.46M | 0.41% | +325,000 | New | +$3.46M |
|
46
Essential Properties Realty Trust
EPRT
$6.21B
| $3.33M | 0.39% | +125,000 | New | +$3.33M |
|
47
Immunome
IMNM
$828M
| $3.27M | 0.39% | +132,500 | New | +$3.27M |
|
48
Immunovant
IMVT
$2.56B
| $3.23M | 0.38% | 100,000 +30,000 | +43% | +$969K |
|
49
Atmus Filtration Technologies
ATMU
$3.66B
| $3.23M | 0.38% | +100,000 | New | +$3.23M |
|
50
Chewy
CHWY
$16.9B
| $3.18M | 0.38% | +200,000 | New | +$3.18M |
|